PHARMACEUTICALS
Developing a lab-grown, GMP-aligned, contaminant-free chitosan source.
Our approach:
Contaminant-free origin – no heavy metals, no PCPs, no micro- or nanoplastics.
Reproducible, standardised MW and DDA, comparable to crustacean sources.
Batch variability removed at the source, improving reliability and reducing risk.
Cleaner cultivated input with no impurities, reducing purification needs.
GMP alignment at the source, supporting regulatory confidence.
Help Us Shape the Future of GMP Chitosan in Pharma
We’re gathering insights from industry professionals to better understand formulation needs, sourcing challenges, and compliance priorities.
Let’s Talk Pharma-Grade Chitosan
Are you exploring cleaner, more consistent chitosan for pharmaceutical applications?
Whether you’re focused on formulation, scale-up, or sourcing GMP-aligned ingredients, we’d love to hear from you.